16.02.2021
CAR-TCR Digital Summit Europe

Glycostem to participate the CAR-TCR Digital Summit Europe during 16th to 18th Feb, 2021, with workshop with our CSO Jan Spanholtz: viveNK™ products (CAR-NK and TCR-NK) as autologous CAR-T alternatives and conference presentation by our CDO Volker Huppert: clinical scale closed manufacture system for allogeneic NK products on.

29.01.2021
8th Solebury Trout Private Company Showcase

Glycostem to present at Virtual 8th Solebury Trout Private Company Showcase, with presentations and 1x1 calls on Friday, 29th January, 2021.

21.01.2021
Advanced Therapy Showcase in Tokyo#1

Glycostem to present at the business partnering event Advanced Therapy Showcase in Tokyo#1 on 21st January at 09.35 CET/17:35 GMT+9 with live streaming.

14.01.2021
Kempen Biotech X-over Selection

The Kempen X-over Selection connects a curated list of private European Biotechs with global institutional investors active in the crossover space. 

15.12.2020
SVB Leerink Biopharma Private Company Connect
Glycostem to participate in SVB Leerink's Biopharma Private Company Connect from 15th to 17th December, 2020, though virtual one-on-one meeting.
18.11.2020
Stifel Virtual Healthcare Conference

Glycostem is invited to participate in the investor conference Stifel Virtual Healthcare Conference on 18th November, 2020, 09:20AM (ET)/15:20PM (CET). Join the meeting through the link to meet our CEO Troels Jordansen.